The first stage of vaccination against dengue with the vaccine developed by the Butantan Institute in São Paulo is scheduled to begin on January 26th. In this initial phase, immunization will be aimed at primary health care professionals, such as doctors, nurses and nursing assistants.
Before that, on January 17th and 18th, the vaccine will be administered to residents aged between 15 and 59 years old in three selected municipalities: Botucatu, in the interior of São Paulo; Maranguape, in Ceará; and Nova Lima, in Minas Gerais.
The expectation occurs amid an alert scenario. A study indicates that Brazil could record around 1.8 million cases of dengue throughout this year. The research, conducted by an international project in partnership with the Oswaldo Cruz Foundation (Fiocruz) and the Getulio Vargas Foundation (FGV), estimates that 54% of notifications should be concentrated in the state of São Paulo.
